Zobrazeno 1 - 10 of 421 pro vyhledávání: '"J. E. Gschwend"'
1
Editorial & Opinion
Re: Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors: K. Herkommer, C. Hofer, J. E. Gschwend, M. Kron and U. Treiber J Urol 2012; 187: 1566-1570.
Autor: Mandal S, Goel A
Publikováno v: The Journal of urology [J Urol] 2013 Jan; Vol. 189 (1), pp. 389. Date of Electronic Publication: 2012 Nov 20.
Zobrazit plný text záznamu
2
Stellenwert der Immuntherapie in der perioperativen Behandlung des lokalisierten muskelinvasiven Harnblasenkarzinoms
Autor: J. Lewerich, S. C. Schmid, J. E. Gschwend, M. Retz
Publikováno v: Die Urologie. 62:279-287
ZusammenfassungImmun-Checkpoint-Inhibitoren (ICI) sind als Erst- und Zweitlinientherapien beim metastasierten bzw. lokal fortgeschrittenen Urothelkarzinom als Standard etabliert. Der perioperative Einsatz der Immuntherapie steht nun im Fokus aktuelle
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::26351fcaabb83ef006eff240fde1c70f
https://doi.org/10.1007/s00120-022-01983-5
Zobrazit plný text záznamu
6
[Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer]
Autor: J, Lewerich, S C, Schmid, J E, Gschwend, M, Retz
Publikováno v: Urologie (Heidelberg, Germany)Literatur.
Immune checkpoint inhibitors are standard of care in the treatment of metastatic and locally advanced urothelial cancer. Their use in perioperative treatment is currently under investigation as monotherapy as well as in combination with chemotherapy
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::31d293b49b884f719573972417c35c4a
https://pubmed.ncbi.nlm.nih.gov/36449033
Zobrazit plný text záznamu
7
[Quality assurance for the treatment of muscle-invasive and metastasized bladder carcinoma in Germany : An initiative of the Working Groups Urological Oncology (AUO) and Internal Oncology (AIO) in the German Cancer Society (DKG)]
Autor: C H, Ohlmann, M, Kerkmann, L, Holtmann, J E, Gschwend, M, Retz, M, de Wit
Publikováno v: Urologie (Heidelberg, Germany)Literatur. 61(12)
The S3-guideline on bladder cancer recommends radical cystectomy and cisplatin-based perioperative chemotherapy (POC) for muscle-invasive bladder cancer (MIBC). Recommendation for metastatic urothelial cancer (mUC) is cisplatin-based or immuno-oncolo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e04885f759b7f42a16859ceda0660cd9
https://pubmed.ncbi.nlm.nih.gov/35925102
Zobrazit plný text záznamu
8
[Internet use after prostate cancer : Search for information and trust in disease-related information in long-term survivors]
Autor: A J, Linden, A, Dinkel, S, Schiele, V H, Meissner, J E, Gschwend, K, Herkommer
Publikováno v: Der Urologe. Ausg. A. 58(9)
The internet provides numerous sources of information about prostate cancer (PCa). The present study investigated internet use among long-term PCa survivors, trust in online PCa-related information, and associated factors.Based on the German national
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b98dcb34cd535a084dde9bf3a4f9b056
https://pubmed.ncbi.nlm.nih.gov/31172242
Zobrazit plný text záznamu
10
[Chemotherapy-induced nausea and vomiting : Current recommendations for prophylaxis]
Autor: E, Storz, J E, Gschwend, M, Retz
Publikováno v: Der Urologe. Ausg. A. 57(5)
The chemotherapy-induced nausea and vomiting (CINV) is one of the most frequent side effects in cytostatic therapy and a profound challenge during the therapy of cancer patients. Therefore, standardized guideline-orientated prophylaxis is essential a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b993ac9999d9592fda15389656cf8835
https://pubmed.ncbi.nlm.nih.gov/29589051
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje